Categories
Acute Myeloid Leukemia (AML) Acute Myelomonocytic Leukemia (AMML) Chemotherapy Leukemia Menin inhibitor Patient Stories Targeted Therapy Treatments

Acute Myelomonocytic Leukemia (AMML): Russ’s Clinical Trial Story

“A Clinical Trial Saved My Life”: Russ’s Acute Myelomonocytic Leukemia (Rare AML) Story

After 48 years of marriage, Russ was blindsided by Acute Myelomonocytic Leukemia (AMML), a rare diagnosis with few options. But a last-minute clinical trial offered a new path. Here is his story of love, surrender, and the “sweet spot” between faith and science.

Interviewed by: Taylor Scheib
Edited by: Katrina Villareal & Jeff Forslund

Russ’s story offers a view into the intersection of honesty, science, and hope. Diagnosed with acute myelomonocytic leukemia (AMML), a rare subtype of AML, after weeks of “just the flu” and crushing fatigue, Russ went from preparing for hospital discharge to learning he had cancer and being told he needed treatment that same night.

When he heard the word leukemia, he thought of death, yet in that moment, a surprising sense of peace set in as he focused on what it was and how to treat it.

The early days were chaotic though. Russ was turned away from one hospital because his insurance plan did not match their funding, forcing him and his family to pivot overnight to UCLA’s emergency department. There, amid what he describes as ground zero conditions in the ER, he endured hours on a hallway gurney, multiple tests, and a 12‑hour wait before finally being admitted to the oncology floor. Even as he grappled with a 7+3 chemotherapy regimen and spent 29 straight days in the hospital, he remembers mostly trying to protect his family as waves of shock rippled through them.​

Russ D. AMML

Behind the scenes, his primary care physician and his family were fierce advocates, pushing for answers and ultimately toward a newly developed clinical trial drug tied to his NPM1 mutation. Russ was too sick to participate in the decision, but his wife and adult children did the research and made the call to enroll him, a choice he says “saved my life.” He now calls himself the poster boy for the trial, still taking the pills daily and returning to UCLA for ongoing labs, doctor visits, and bone marrow biopsies.​

Today, Russ lives in deep remission and talks about inhabiting the sweet spot where faith and science intersect. He credits his family’s constant presence, the insight of his oncology team, and the existence of a trial drug that arrived just in time for him.

For others with AMML, he encourages surrendering to trusted clinicians, considering clinical trials seriously, learning about your biomarker, and allowing community, spirituality, and modern medicine to work together in the service of one more good day.​

Watch Russ’s video or read the transcript of his interview below to dive deep into his story:

  • How Russ’s acute myelomonocytic leukemia symptoms first looked like the flu
  • How insurance and hospital systems can create major obstacles, and the importance of having advocates who help navigate where to go next to change the course of care
  • Why clinical trials are not last-resort gambles—and how exploring them from the start is the reason he says he is alive.
  • How trusted loved ones and clinicians are essential partners in making sense of complex choices and next steps
  • Russ describes a profound transformation from shock and uncertainty to “deep, deep remission,” learning to live day by day in a balance of faith, science, and gratitude

  • Name: Russ D.
  • Age at Diagnosis:
    • 68
  • Diagnosis:
    • Acute Myelomonocytic Leukemia (AMML), a rare subtype of Acute Myeloid Leukemia (AML)
  • Mutation:
    • NPM1
  • Symptoms:
    • Flu‑like symptoms
    • Profound fatigue
    • Blood pressure drop
    • Shortness of breath
  • Treatments:
    • Chemotherapy
    • Clinical trial drug: menin inhibitor
Russ D. AMML

Kura Oncology

Thank you to Kura Oncology for their support of our independent patient education program. The Patient Story retains full editorial control over all content.


This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.



Nancy and I met in a nightclub back in 1976… and we have been dancing for 48 years.

Russ D., AMML Patient

Who I Am

I’m probably most known for my passion for life. That extends to enjoying living, my family, music, and sports. I’m pretty passionate and can be moved by the things that I love and enjoy.

Our Love Story: Meeting My Wife in 1976

Nancy and I met in a nightclub back in 1976. I went to this nightclub with a buddy. I saw him dancing with a hot blonde while I was standing against the wall with a beer. I said, “Man, if he doesn’t ask her to dance again, I’m going to swoop in.” He went left, she went right, and I dashed right in and put my arm around her. I said, “Would you like to dance?” and we have been dancing for 48 years.

Russ D. AMML
Russ D. AMML

Knowing She was “The One” and the Secret to 48 Years of Marriage

I told her I loved her within two days. I was somewhat bitten by the “love at first sight” cliché, and it proved to be a good choice. We were engaged after two weeks.

Your love deepens as the years go on. It validates your early love, but then your ongoing love strengthens. It’s the recognition that you love her and you’re going to do what you need to do to keep that relationship going. That’s in light of mistakes, challenges, and difficulties, but also a lot of good times, a lot of laughter, and a lot of joyous living.

Your love deepens as the years go on. It validates your early love, but then your ongoing love strengthens.

Russ D., AMML Patient

Marriage Through Cancer: A Bond Forged in Suffering

My family all thought they were going to lose me, and I have a significant place in our family system. Never having gone through anything of this kind, it was such an emotional devastation to my wife and to my children. My wife stayed strong for my children. She was there for them, but she was there for me, too, and she was as determined as I was to see me well. We both felt like we had life to live.

I never winced once about having cancer. I never cried about it. I just said, “Okay, what have we got to do?” and my wife was the same, right there by me. Our love has deepened as a result of that. Love deepens if you allow it to, and our marriage and relationship are in one of the best places they have ever been in our lives. It is a bond created through suffering that is real and absolutely unbreakable.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

Living with Fear, Gratitude, and “Self-Contained” Feelings Today

At times, I feel very self-contained. Not isolated, but within myself. I manage the fears and concerns, and I try to live and savor each day. At times, it is a little bit lonely because I want to be brave for my family and my wife. There are things I manage that I do not tell people about. If there were something really dire, I would. But there is this curiosity of a question: how long do I have?

I had a very rare form of leukemia with not a good prognosis, but here I am feeling as good as I could possibly feel. I am grateful for today. I will do the things today that I always do, and I will continue to beat the drum of being encouraging to others and being caring, seeing people, and being who I am. I definitely feel a bit inward and self-contained at times. It’s like nobody knows what I am going through but me. It’s a little tricky.

It is a bond created through suffering that is real and absolutely unbreakable.

Russ D., AMML Patient

My First Red Flags Before My Diagnosis

I had been at a local hospital for two other stays before I went to UCLA. We thought I had the flu. I was on the couch for a couple of days, but I wasn’t getting better. I had a lot of flu symptoms and fatigue. Then I had a real blood pressure drop, which was scary for both of us. We called our primary care physician and she said, “Go to the hospital.” I was in the hospital for the first stint. I’m sure I was a bit dehydrated. They gave me an IV, kept me under observation, ran some tests, and sent me home with no diagnosis.

Over the next three weeks, I knew something was wrong because I couldn’t walk from my car to my house without being exhausted. The fatigue factor was profound. I would lie on my wife’s lap and say, “I am so tired.” I was so down. My primary care physician had me take a blood test, and it came back with my white blood cells at about 40,000. She said, “Get right to the ER.” I went back, and they diagnosed me with acute myelomonocytic leukemia (AMML) at Providence. They diagnosed it, but they do not treat it. They told me I needed treatment that night.

I cannot tell you the sheer shock. It was surreal, but I felt this peace come over me that said, “Okay, we have to deal with this.” Meanwhile, it was like shock waves running through my family, and I was trying to maintain for them. The shock was real, but the main red flags had been flu-like symptoms and serious fatigue that ultimately led to the diagnosis.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

What We Thought During Those Three Weeks Before Diagnosis

We didn’t think it was anything like leukemia. We knew something was wrong, but because I had been largely healthy throughout my life, we thought, “There’s something, but we will take care of it.” There was an optimism. It never dawned on us that leukemia was the culprit. Those three weeks were filled with questions: “What’s going on?”

I am a high-energy guy. For me to have fatigue was alarming to everyone. People were freaking out, asking, “What is wrong with Dad?” because I am usually high-energy. Our minds never went to the dire reality we eventually faced — nothing close.

I couldn’t walk from my car to my house without being exhausted.

Russ D., AMML Patient

A Primary Care Doctor and Wife Who Advocated Hard

My primary care physician was very much on top of things and advocating for me. She was in our corner and treated me with what she knew. When the blood test came back with the accelerated white blood cells, she said, “Get to the ER right now.”

It takes a lot to get me to go to the hospital. I tend to be a little bit too chivalrous or stubborn. My wife was also really urging me. She was consulting Doctor Google, researching and reading, and she did not like what she was seeing. It did not take much for her to get me going as well.

blood vials
Russ D. AMML, a rare subtype of AML

The Moment Everything Changed

That afternoon, I had already been in the hospital for three days, and they told me I was being discharged at 2 p.m. I was actually feeling better after they had treated me a bit. I was packed up and ready to go home. Two o’clock, three o’clock, four o’clock went by.

By 4 p.m., I asked the nurse, “We were supposed to be discharged.” She said, “The doctor has not signed the orders yet.” At 6 p.m., the nurse came into our room with a phone. The doctor was on the phone telling my wife and me that I have acute myelomonocytic leukemia and that I needed to get treatment right away by going to downtown Los Angeles and going to USC.

When the blood test came back with the accelerated white blood cells, [my primary care physician] said, ‘Get to the ER right now.’

Russ D., AMML Patient

That moment was surreal and mind-boggling. Nancy was very afraid, and so was I. We’re older, so when I heard the word leukemia, I always thought of death. I asked the doctor, “How long do I have?” It was like going from 0 to 100 — from just living life to, “What?!” A peace settled on me. I cannot say I was fearful. I was more asking, “What is this, and how do we get after it?”

I had no idea at that point that without the clinical drug, there wasn’t much of a treatment opportunity. We were caught flat-footed and knew nothing about it. We have an education now, believe me. My wife was very upset, unhappy, and concerned. We held each other, moved into the discharge process, went home, picked up a couple of things, and drove down to what we thought was USC Medical Center.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

Telling the Kids and Family in the Middle of the Chaos

We went to that medical facility, which was supposedly USC, but USC had sold its building to a public medical group. It was not what we expected. My daughters came down, and I hugged them, but I was inside the building trying to get treatment and move through their process.

My wife handled the bulk of communicating with the entire family about my situation. That was brutal. She was a great mom and was there for them, but it was very tough. My youngest daughter was absolutely undone. She was worried I would not be there for her marriage. She had a serious boyfriend and feared I would not walk her down the aisle. She had a lot of angst, and her boyfriend, her fiancé, was seeing this for the first time and was overwhelmed.

My oldest daughter was emotional but very strong. My wife also had to tell my son, and he and I are very close. That was a tough conversation for both of them. The family had initial fears, concerns, and tears, but then it became, “Okay, what have we got to do here?”

When I heard the word leukemia, I always thought of death.

Russ D., AMML Patient

Insurance Rejection and Being Turned Away While Needing Treatment

I was in a back room getting tests, holding paperwork that the Providence doctor had given me. He said, “Show this paperwork and you will get admitted anywhere.” That wasn’t the case. I had to go through all these tests. I spent seven hours in that back room waiting and talking.

At the end of seven hours, a financial manager asked me to come into an area. She said my Medicare Advantage plan did not sync with their public funding, so they couldn’t treat me there. We went from 0 to 100, thinking we would go there and get treatment. We had prepared for that. Instead, she basically said, “You will have to leave. We cannot treat you here.”

insurance policy TOC
Russ D. AMML, a rare subtype of AML

I had already released my family to go home because it is about a half-hour drive from where we live. Around 11 p.m., I called my wife and my daughter Danielle and said, “I need you to come pick me up. They’re rejecting me because of the funding.” They asked, “What are we going to do?” I said, “Come pick me up. Let’s get a good night’s sleep if we can, and I will deal with this in the morning.”

I slept well that night, but my wife didn’t at all. In the morning, we called an oncologist whom Providence was going to connect us with. This doctor had never seen me in the hospital, but was on the phone. She said, “Go to UCLA and be really sick, because you are going to have to go in through the ER. Take your paperwork and go through their emergency room.” That is where we headed in the morning.

My Medicare Advantage plan did not sync with their public funding… They’re rejecting me because of the funding.

Russ D., AMML Patient

We Had to Pivot to UCLA

I knew nothing about a biomarker at that point. I was just trying to remember the name of what I had. I was not “AMML-ing” it very well. My oncologist at Providence had told me, “Pretend that you’re very sick at UCLA.”

We arrived and waited in a tent outside in a parking area and it was cold. When I got in, the UCLA ER looked like the ground zero of a battle. There were people everywhere, gurneys, IV drips — everything. I went through a variety of stations, and my wife Nancy and my daughter Ally came with me. At one point, I was really in anguish — or pretending I was — and really doing my best to make myself seem very sick. My daughter Ally asked my wife, “Is Dad really hurting that bad?” I pulled down my mask, looked at her, and winked, so she knew I was not that bad.

They told me they were going to admit me, but didn’t know when. They put me on a gurney in a long hallway with bright recessed lighting. It was like a traffic jam on the freeway — gurney after gurney wrapped around the building. I don’t even know how the doctors and nurses kept track. I received good treatment there; they checked on me, made me comfortable, and did more tests.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

We arrived around 10:30 a.m. I was put on a gurney around 1:30 or 2:00 p.m. Eventually, they tucked us into a little side room where my gurney barely fit. It was more private because they knew they were going to admit me. A doctor came in and said, “This is what you have. It’s very treatable. You’re going to be just fine.” That wasn’t true, but we didn’t know that, and we took great comfort in it. She even prayed for me, which was very kind.

We sat in that small room until about 9 p.m. Then we were ushered into UCLA Ronald Reagan on the oncology floor. It took about 12 hours to get a room.

My care practitioner got me settled for the night, started a drip line, and I was attached to that pole for the next six months for the most part. It was a simple “Welcome, get in, and let’s set up what we need.” I told my wife she needed to go home. She was not happy about it. She spent several nights with me over time, though I’m not sure if she spent the night that first night.

They started testing in the middle of the night, so I got very little sleep. Providence had sent all its paperwork, so UCLA had a baseline, but they wanted to run their own tests. They did that through the night and into the next day, and they started chemo on the second day.

I didn’t know what a clinical trial was or how it would impact me… She said it would be very exciting if I qualified because of the NPM1 mutation.

Russ D., AMML Patient

First Time Hearing About the Biomarker and Clinical Trial Option

My first oncology doctor came to check on me and talk with my wife, my daughter, and me about the possibility of a clinical trial drug, of which I was thoroughly uninitiated. I didn’t know what a clinical trial was or how it would impact me. At that point, I had an IV pole with about 10 different bags running into me. I’m not a big pill-taker, and I had lost control of my life. All these choices were being made on my behalf. I was just along for the ride.

I remember her talking about this drug. I don’t remember her using the word biomarker. She talked about a mutation. That was the first time I heard anything about it. She said it would be very exciting if I qualified because of the NPM1 mutation. That was the first time my family and I heard it, but then nothing more was said for several days, until it actually got in motion.

I was in a bad way, dealing with the seven-day, round-the-clock 7+3 regimen. I had a rocky five or six days. While I was struggling, the clinical drug decision process was going on. My daughter and her husband had done a deep dive into the drug, and my wife had a close family friend with bladder cancer whose life was saved by a clinical drug. Between their research and that recommendation, my family moved toward the trial, even though others initially did not want me to suffer more after hearing about the side effects. My son and my other daughter relented, and we decided to go for it.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

My Family Made the Clinical Trial Decision and Saved My Life

They saved my life.

We did not have any other option. This drug had just been developed a few months before my diagnosis, so we believed it was a God thing. If I had been diagnosed a year earlier, I probably would have been gone by now. My prognosis was not favorable. There wasn’t anything else.

I was grappling with trying to get through the chemo. I remember being shivering cold, never able to get warm, and being in and out of sleep with violent dreams. My vision became extremely blurry for a while, which was very scary. I couldn’t focus on anything, which was terrifying. I was wondering if I was losing my eyesight. While I was in that state, my family was discussing the clinical drug. It wasn’t something I could participate in. When they explained it to me, I said, “Fine, let’s do it.”

The two people running the trial came in and handed me the paperwork. I signed it while on my bed. From that point forward, I was taking two pills a day.

We did not have any other option. This drug had just been developed a few months before my diagnosis, so we believed it was a God thing.

Russ D., AMML Patient

Learning to Live Around the Trial Drug Schedule

I tried to get them to give me the pills at the same time each day. You couldn’t have anything in your stomach two hours before taking them and then an hour after. It felt like madness. I tried to get them on a routine: “I will have lunch, you come in at 4 p.m., give me my pills, and I will have dinner at 5 p.m.” It took a week to get them aligned.

At that time, I followed the timing rules very strictly. Now I fudge here and there. They have since told me they don’t know exactly what should be done regarding food intake, because food actually integrates fine with the pills. Waiting two hours before and one hour after may be overwrought. I was very fastidious about it then, though.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

The Power of Family Support and My Goal of Being a Father

Our family is close. I love being a dad. My wife is an incredible mother. We have always had good relationships with our kids and loved raising them. All my kids and grandkids live within 20 minutes of us, so we’re always together.

I did not grow up with a father who cared about me or even talked to me. There was no connection between us. Becoming a father was a real goal of my life. A lot of people have goals of success. I wanted to be a father. I didn’t know how poor my upbringing was until I became a father myself. I dreamt of being a dad, and it came to pass. The greatest source of joy in my life is my family.

Them caring for me was very humbling. I was at UCLA for 29 straight days during that first stint. My wife, daughters, and son-in-law spent the night with me at different times. I had someone at the hospital every day but one. I was very focused on beating this and having life, and my family was the primary inspiration for that.

Them caring for me was very humbling… I was very focused on beating this and having life, and my family was the primary inspiration for that.

Russ D., AMML Patient

How I Think About Clinical Trials Now

For me, the clinical trial has always been a very positive point of reflection.

I came to understand how rare my cancer was and that there wasn’t much that could be done without this drug. Once we started, I never wavered about being part of it. I felt I was helping, and now a drug related to mine has become FDA-approved. The company that manufactures it has been gracious and kind to me because I was one of the first people to take the trial drug upon diagnosis. The FDA approval initially came for those who had relapsed, but they saw the drug work in me at diagnosis.

I felt it was a real privilege and I was very grateful. I told the company, “Anything I can ever do for you, I will.” I have done some speaking for them. I felt good about helping others, forwarding healing for people coming after me. When I reflect on it, I’m always glad to be part of it and willing to do anything I can to further healing for others.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

Life on a Clinical Trial: Monitoring, Visits, and Bone Marrow Biopsies

After being discharged from the 29-day hospital stay, the clinical drug protocol required me to return to UCLA twice a month initially. The first appointment of the month was just labs. The second was labs plus a doctor’s checkup. That went on for seven or eight months. Now it’s once a month at UCLA, where I do labs and see the doctor at the same visit.

I also still get a bone marrow biopsy every 90 days. I just had one about a month ago, and everything came back MRD-negative. We are about six months away from the end of the two-year trial, so something will shift at that point, but I am not sure how yet.

I still take the trial pills. I used to take two pills a day; it’s now three pills a day and has been for six or seven months. I take them in the afternoon. With the first one, I say a small prayer of thanks: “Lord, thank you for [this drug] and that it has become FDA-approved.” With the second, I say, “Thank you for its ongoing efficacy in my body to bring healing.” With the third, I say, “May it always be potent, may I never die of cancer, and bless oncology.”

With the first one, I say a small prayer of thanks: ‘Lord, thank you for [this drug] and that it has become FDA-approved.’ With the second, I say, ‘Thank you for its ongoing efficacy in my body to bring healing.” With the third, I say, ‘May it always be potent, may I never die of cancer.’

Russ D., AMML Patient

Having Extra Eyes on Me

Being in a clinical trial means there are extra eyes on you — extra monitoring, extra visits, and extra biopsies. That hit me early, and I took to it like a duck to water because I felt it was part of my recovery. My wife and I have to drive down to UCLA on a major thoroughfare and fight traffic. It’s not always convenient, but my feeling is that we need to be the best patients, the most pleasant, and grateful people we can be. Let the eyes be on me.

I welcome that because it gives the team more data and information. It can help with this nasty disease. I jokingly call myself the poster boy for this clinical drug because I was one of the first to get it upon diagnosis, so they watch me very closely. I embraced my poster boy responsibilities.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

What I Tell People Who are Considering Clinical Trials

If I were sitting in front of a group of people who might know something or nothing about clinical trials, I would start by saying: clinical trials saved my life. I am here today because of a clinical trial drug.

I would encourage you that if there is an available trial drug, do your research, talk with your doctors and caregivers, and seriously look at it as a means by which you embrace treatment that is the absolute best for you. I admit I have a bias; the clinical drug saved my life, so I am a strong proponent. Every person is different, and every situation warrants its own process, so do your process. But if you are going to lean in and need a little help deciding which way to go, I am going to nudge you toward the trial.

Clinical trials saved my life. I am here today because of a clinical trial drug.

Russ D., AMML Patient

Learning About My NPM1 Mutation

The process of discovering the mutation and biomarker was not discussed with me at the time. They did the tests and used the results to guide my treatment.

Later, one of the doctors in the entourage wrote everything down for me on a sheet of paper: the NPM1 mutation, some details, and clarifications. I still keep that piece of paper on my desk. It was the first time I truly understood anything. Up to that point, everything had been verbal, and it did not fully land with real cognition. That paper was a breakthrough moment for me.

It was also the day they told me I was in deep, deep remission. I had never heard of anyone being in “deep, deep remission,” only remission. My oncologist called it “deep, deep,” so I quote him on that. The paper is special because she took the time, on her own initiative, to write it out and make it clear to the degree a layperson could understand.

Russ D. AMML, a rare subtype of AML

It was a breakthrough moment for me to understand, and it was also the day they told me I was in deep, deep remission.

Russ D., AMML Patient
Russ D. AMML, a rare subtype of AML

The Communication Gap Between Doctors and Patients

It’s important to humanize all of this because there’s so much information being thrown at you. In my case, it was not backwards, but they knew what to do with me. They knew about the clinical trial and my mutation, which was reassuring.

However, there’s a disconnect between the medical field and patients. Medical professionals are so busy and consumed that they look for the shortest paths to communicate and fulfill their jobs. They take for granted that patients will understand information to a certain degree. There are rare doctors who make it simple, and that is genius: having tremendous knowledge but breaking it down so anyone can understand.

A lot of doctors do not seem to enjoy that part of communicating with patients. They may trivialize it because they’re focused on saving lives. That creates disconnect and frustration for patients and families. I’m not judging them; I respect their learning, work, and time. It’s just a reality. What helps is follow-up, like when a couple of nurses came back into my room to help me understand more. That was very valuable.

Genius is tremendous knowledge broken down so anyone can understand.

Russ D., AMML Patient

Keeping lines of communication with the care team open is crucial, but it’s hard for one person to hold all the information. My wife was so focused on me that she did not understand a lot either. My oldest daughter became an advocate, but she eventually had to drop off because she has a family and responsibilities. During that first month, she was all over it by helping explain, fielding conversations, and taking on discussions I couldn’t have because I wasn’t well enough. My wife was too concerned about me to shoulder it all.

It’s a reality that some doctors’ personalities are not geared toward the communicative side. Family members or advocates who can help digest and interpret are incredibly important.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

Navigating the Future: Labs, Remission, and Living Day by Day

Now, I can read my labs and know what I am looking at and looking for. I understand the terminology regarding my biopsies. The future is not really discussed. I do not know how to discuss it, which is why I try to savor each day and enjoy it for what it is.

My primary oncologist has said one key thing: every day you do not relapse makes it more likely that you will not. As far as the future is concerned, I live on that. I do not have bad days. I have never been someone who comes home and says, “I had a bad day.” As far as I know, I am totally cancer-free. That is a good day. Whatever else happens is icing on the cake — and I like lots of icing, especially on carrot cake, which my wife is making for Thanksgiving.

Live your life in the sweet spot of faith and science.

Russ D., AMML Patient

There isn’t much dialogue about the future because it is unknown. My oncologist looks at me and says, “Russ, you’re doing good, man. Keep it up.” He is the director of stem cell research and training at UCLA. He did not push me in that direction, even though it would have been natural. He walked with me and watched me. He told me I had options, which many people do not have. He laid out my options but didn’t tell me what to choose. That was up to my family and me.

Living at the Intersection of Faith and Science

I live in the sweet spot of the intersection of faith and hope. You need people praying for you and a community around you. You want to consider spiritual truth to build your faith and strength to fight your disease.

However, do not allow faith to short-circuit your belief in science. A drug was made for me at the right time in my life that saved my life. God blesses great minds with creativity and the ability to do great things for their fellow human beings. Take advantage of that. Where those tools overlap, live your life in the sweet spot of faith and science.

Russ D. AMML, a rare subtype of AML
Russ D. AMML, a rare subtype of AML

Surrender, Trust, and “Letting Them Bake the Cake”

If I had one main piece of advice for people with AMML or cancer, the word that comes to me is surrender. Place your life in the hands of your higher power — your God, whatever you believe is larger than you and gives life. Surrender to the knowledge and wisdom of experienced doctors.

My primary care physician said to me, “UCLA has the recipe to bake the cake.” I have always trusted that they have the recipe, and they baked a cake for me. Surrender to God, surrender to the doctors, and embrace peace and savor it.

Another hard part is realizing your life is not your own. You have to accept that. If you try to micromanage every detail, you are not going to make it. I was an advocate to a point, and my wife and daughter were advocates too, but a lot happened because we trusted the wisdom and experience of the doctors. You can fight that truth or surrender to it. I surrendered, though it was not always easy.

Surrender to God, surrender to the doctors, and embrace peace and savor it.

Russ D., AMML Patient

Russ D. AMML
Thank you for sharing your story, Russ!

Inspired by Russ's story?

Share your story, too!


Kura Oncology

Thank you to Kura Oncology for their support of our independent patient education program. The Patient Story retains full editorial control over all content.


This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.


More Acute Myeloid Leukemia (AML) Stories

Russ D. AMML, a rare subtype of AML

Russ D., Acute Myelomonocytic Leukemia (AMML), with NPM1 Mutation



Symptoms:Flu‑like symptoms, profound fatigue, blood pressure drop, shortness of breath

Treatments:Chemotherapy, clinical trial (menin inhibitor)
Shelley G. acute myeloid leukemia

Shelley G., Acute Myeloid Leukemia (AML) with NPM1 Mutation



Symptoms: Fatigue, rapid heartbeat, shortness of breath, low blood counts
Treatments: Chemotherapy, clinical trial, stem cell transplant
Joseph A. acute myeloid leukemia

Joseph A., Acute Myeloid Leukemia (AML)



Symptoms: Suspicious leg fatigue while cycling, chest pains due to blood clot in lung

Treatments: Chemotherapy, clinical trial (targeted therapy, menin inhibitor), stem cell transplant
Mackenzie P.

Mackenzie P., Acute Myeloid Leukemia (AML)



Symptoms: Shortness of breath, passing out, getting sick easily, bleeding and bruising quickly

Treatments: Chemotherapy (induction and maintenance chemotherapy), stem cell transplant, clinical trials
Load More

Categories
ALK Lobectomy Lung Cancer Non-Small Cell Lung Cancer Patient Stories Surgery Treatments

Stephanie’s Stage 2 ALK+ Non-Small Cell Lung Cancer Story

Stephanie’s Stage 2B ALK+ Non-Small Cell Lung Cancer Story

Stephanie’s stage 2 lung cancer story began with a mild, intermittent cough in the spring of 2021, which she dismissed as allergies or weather-related. When her cough persisted, she mentioned it during a routine check-up with her general practitioner. After a chest X-ray, a mass was discovered on her lung. This led to a CT scan, which revealed a spiculated mass (having spikes or points on the tumor surface), raising concerns about cancer.

Interviewed by: Nikki Murphy
Edited by: Katrina Villareal

The diagnosis came after a bronchoscopy, which confirmed the mass was cancerous, specifically adenocarcinoma, a type of non-small cell lung cancer. She underwent a lobectomy, during which her surgeon removed two lobes of her lung to ensure all cancerous tissue was eliminated. Stephanie was subsequently diagnosed with stage 2B lung cancer. The pathology report confirmed that her lymph nodes were cancer-free and that she had clean margins with no signs of vascular or pleural invasion.

Stephanie W. feature profile

Following her surgery, Stephanie learned she was ALK-positive, a genetic mutation associated with non-smokers and younger lung cancer patients. Due to this, her treatment plan included chemotherapy and targeted therapy. After completing four rounds of chemotherapy, Stephanie was advised to begin targeted therapy, which is typically used in stage 4 cases but has shown potential benefits for earlier-stage patients, like her stage 2 lung cancer. Stephanie decided to follow this advice and has been on targeted therapy since completing chemotherapy.

Stephanie’s motivation throughout her diagnosis and treatment has been her young daughter. She remains dedicated to doing everything to stay healthy for her family. While she has had clean scans and blood work for the past three years, she continues to take her medication daily, hoping it prevents the cancer from returning. She advises others to know their biomarkers, seek second opinions, and join support groups for personalized guidance and support.


  • Name: Stephanie W.
  • Age at Diagnosis:
    • 37
  • Diagnosis:
    • Non-Small Cell Lung Cancer
  • Staging:
    • Stage 2B
  • Mutation:
    • ALK
  • Symptoms:
    • Persistent cough
    • Wheezing
  • Treatments:
    • Surgery: bilobectomy
    • Chemotherapy
    • Targeted therapy
Stephanie W.
Stephanie W.
Stephanie W.
Stephanie W.
Stephanie W.
Stephanie W.
Stephanie W.

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.

The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.


Stephanie W. feature profile
Thank you for sharing your story, Stephanie!

Inspired by Stephanie's story?

Share your story, too!


More Non-Small Cell Lung Cancer Stories

Jennifer M. EGFR-positive lung cancer

Jennifer M., Non-Small Cell Lung Cancer, EGFR+, Stage 4 (Metastatic)



Symptoms: None per se; discovered during physical checkup for what seemed to be a sinus infection

Treatments: Radiation therapy (stereotactic body radiation therapy or SBRT), targeted therapy
Dr. Ross Camidge stage 4 lung cancer

Dr. Ross Camidge, Non-Small Cell Lung Cancer, Stage 4 (Metastatic)



Symptoms: sore shoulder muscle, breathing sounded different
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Drea C. stage 4 ROS1+ lung cancer

Drea C., Non-Small Cell Lung Cancer, ROS1+, Stage 4 (Metastatic)



Symptoms: Swollen ankle resulting from a deep vein thrombosis or blood clot, mysterious bruising, extreme weight loss, persistent shortness of breath, rattling sound coming from the throat while breathing

Treatments: Radiation therapy, chemotherapy, targeted therapies
Lysa B. stage 4 ROS1+ lung cancer

Lysa B., Non-Small Cell Lung Cancer, ROS1+, Stage 4 (Metastatic)



Symptom: Severe but intermittent back pain

Treatments: Chemotherapy, radiation therapy, targeted therapy (including through a clinical trial), surgeries (lung resection, metastatic spine tumor surgery)

Categories
Bispecific Antibodies Chemotherapy EGFR Lung Cancer Patient Stories Radiation Therapy Stereotactic body radiotherapy (SBRT) Surgery Treatments

Filipe’s Stage 4 Lung Cancer with EGFR exon 19 Deletion Story

Filipe’s Stage 4 Lung Cancer with EGFR exon 19 Deletion Story

Interviewed by: Taylor Scheib
Edited by: Katrina Villareal

Filipe P. feature profile

Filipe was diagnosed with stage 4 lung cancer at 36. He reflects on the challenges and critical decisions that shaped his treatment path. Being a nonsmoker, he was shocked by his diagnosis following a severe headache that prompted a brain MRI, revealing multiple metastases in the brain and a primary tumor in the lung. Despite disbelief and seeking second opinions, doctors confirmed the advanced stage of his condition.

The treatment began with brain surgery to address a 4 cm metastasis. Biomarker testing revealed an EGFR mutation, enabling targeted therapy that initially worked well. However, disease progression after nine months necessitated further interventions, including chemoablation for kidney metastases and SBRT for lung activity. Eventually, a new line of treatment with a bispecific antibody offered hope when options dwindled.

Managing side effects became a significant focus, especially as the current treatment led to severe skin issues and nail problems. Adjusting the treatment schedule provided some relief. Emphasizing the importance of second opinions and advocating for personalized care, Filipe highlights the need for patients to be informed and assertive. Despite setbacks and fears of running out of options, he remains hopeful, crediting research and innovation in lung cancer treatments for extending his life.


  • Name: Filipe P.
  • Age at Diagnosis:
    • 36
  • Diagnosis:
    • Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • EGFR exon 19 Deletion
  • Symptom:
    • Headache
  • Treatments:
    • Surgery: to remove brain metastasis
    • cryoablation: to remove kidney metastasis
    • Targeted therapy
    • SBRT
    • Bispecific antibody
Filipe P.

Johnson & Johnson - J&J

Thank you to Johnson & Johnson for supporting our patient education program! The Patient Story retains full editorial control over all content.

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make treatment decisions.



Introduction

I was diagnosed with stage 4 lung cancer at the age of 36. I’m married and I have a daughter. I have electronic hobbies.

Before my diagnosis, life was well. I was an IT systems administrator for an insurance company. My daughter was five years old when I was diagnosed.

The MRI revealed seven brain metastases and a 4 cm metastasis on the back of my head.

How I Found Out I Had Lung Cancer

I used to say I’m healthy all the time. I don’t have behaviors that justify my diagnosis, so it was a shock.

I was very lucky because my diagnostics took one day. When I had a headache, I went to the doctor and the first thing the doctor asked me to do was a brain MRI. When I was in the MRI machine, the technician asked me to wait because he wanted to call the doctor. I asked him why because the result takes at least one week. He said the doctor needed to see it.

The MRI revealed seven brain metastases and a 4 cm metastasis on the back of my head. For the doctors, it was very easy to diagnose because there was evidence. I had brain surgery two weeks after my MRI. They told me that the primary cancer would probably be lung because lung cancer usually metastasizes to the brain very quickly. They did a CT scan and biopsied the primary site and confirmed that I had stage 4 lung cancer.

At the appointment with the doctor, my wife was with me. When he said that it was cancer, I didn’t want to believe it because I never smoked in my life. I was healthy. I usually don’t go to the doctor, so it was very awkward for me. I started thinking about second opinions, but the doctor said there was no doubt about it. It was a shock.

Filipe P.
Filipe P.

Preparing for Brain Surgery

I went to the hospital. They double-checked everything with a CT scan and confirmed that it was lung cancer.

The first CT scan showed lesions on my liver. Fortunately, it was benign, but they found cancer in my bones, my left lung, and my head. They told me that I needed brain surgery right away because the 4 cm metastasis on my brain wouldn’t go away with other therapies. The brain is the last place a patient wants to have surgery.

The doctor said it was a very easy surgery. When they removed the bone, they were able to immediately take it out.

I started at a private hospital where I was diagnosed. They wanted me to undergo radiotherapy for my brain. I asked for a second opinion at a cancer center and they said the brain metastasis would not respond to radiotherapy and that I needed to have brain surgery. Because I’m a nonsmoker patient, I will probably have a mutation and if I’m eligible to undergo targeted therapy, usually the metastases respond very well to this kind of therapy.

I started to be treated at the cancer center. I had brain surgery to remove the biggest metastasis. After it was confirmed that I had the EGFR mutation, I started with a targeted therapy that’s very common for EGFR patients.

Second opinions are very important. There is a small margin of error in this disease. If you don’t choose the treatment well, you may not be able to choose another treatment. Listening to the doctors is very important. Get a second opinion or even a third opinion.

There were no other options for me at the time. I was very lucky because the metastasis was on the surface, so the doctors didn’t need to navigate into my brain to remove it. It only took 50 minutes. The doctor said it was a very easy surgery. When they removed the bone, they were able to immediately take it out. They didn’t need to do a whole lot.

Brain surgery is tough to think about, but it needs to be done. I wrote a letter saying goodbye to my family for them to open in case I die. Fortunately, everything went well and 24 hours later, I was standing up and walking.

Filipe P.
Filipe P.

Learning About Biomarkers

At the time, I didn’t understand why biomarkers were so important. Knowing your biomarker will define what kind of treatment you can have. It’s an expensive exam, but it’s very much needed because the biomarker will allow you to choose the best treatment for your cancer. The biomarker could save your life.

Targeted Therapy Worked for Nine Months

The average progression-free survival of the targeted therapy that I underwent is 18 months. I had a very short run. It only worked for nine months. The first few months were very good because it cleared four brain metastases. It also cleared my bone and reduced the cancer in my primary site.

After three months, I started to have early progression. A metastasis appeared in my kidney. We did a needle biopsy and a biomarker test to confirm if it was the same cancer because it’s very unusual for lung cancer to metastasize on the kidney. When it was confirmed that it was the same cancer, we did cryoablation on the kidney. We froze the metastasis with argon to kill the cancer cells. I also had SBRT on my lung because my lung started to have activity on the primary site based on a PET scan.

After nine months, in August 2023, I had severe progression. At the time, I had no other options on the market.

Knowing your biomarker will define what kind of treatment you can have.

Finding Another Line of Treatment

I was very lucky because my current treatment, which is a bispecific antibody, is only used for EGFR exon 20 and I am exon 19. I was very lucky because I had no options left. Amivantamab appeared and I had a great response to it.

I was very lucky because the drug came out. It’s frightening to think about running out of options and only relying on drugs that aren’t effective for your disease.

It’s similar to the sensation of when you receive the diagnosis thinking that you’re going to die, but this time, I have more information. I know exactly what my options are and even though they’re very few, I’m more aware of what’s happening. In the beginning, everything is new and you start to collect more information. But when I had the progression, I knew exactly what was going to happen.

Filipe P.
Filipe P.

Side Effects of the Current Line of Treatment

With targeted therapy, you can take one pill a day at home and have a normal life. With amivantamab and chemotherapy, you need to stay at the cancer center for six hours every three weeks. It’s not targeted, so it attacks the cancer cells but also the healthy cells, so you need to deal with the side effects.

It’s not as comfortable as targeted therapy. You need to reorganize your life according to the infusion days. If the toxicity is too high, I can postpone for one week, so sometimes I do four-week intervals instead of three. The major side effect is the skin and that’s why I have these pimples all over my body. I also have a lot of nail problems.

The side effects started to manifest weeks after taking the drug. It started with pimples and because I’m on blood thinners as well, everything was full of blood. After two or three months, I reached the peak of my side effects, and the side effects started to smoothen. Right now, only the nails are my major problem.

I used to have various scalp problems, pimples, and blood, but after almost 11 months, it’s only the nails and scalp. I control it with topical corticoids. I used to put a lot of cream, but it wasn’t enough. I need to take corticoids when I have treatments; otherwise, the skin becomes very red and has sunburn-like pain.

The rash is very tough because, for example, when I take a bath, I cannot use a towel and rub my skin. After all, it hurts a lot. I need to dry it very carefully with a towel. I stopped wearing white because you will see blood sometimes. The pain is also associated with that. Sometimes I’m unable to do normal things when I experience the peak of my side effects. For example, I cannot wear sneakers because it’s closed and I have nail problems on my feet, so I wear flip-flops all the time. The main problem is it doesn’t heal. Whatever you do, it doesn’t heal 100%. It can get better, but it never heals.

The toxicity starts to accumulate. In the beginning, it’s only one or two nails. Nowadays, it’s all of them. I only have one finger without problems. The rash is tough, but at some point, it starts to be manageable because you know your body, so you know what to do and know to avoid some troubles.

I’m a stage 4 lung cancer patient with brain metastasis. Forget the skin.

Communicating with My Doctors About the Side Effects

Doctors need to be careful with how to deal with their patients. They usually say that if they cannot control the side effects, treatment may be stopped and the patient starts to hide their side effects because they’re afraid of stopping treatment.

My dermatologist told me that in the beginning. If my skin becomes very bad, we need to stop treatment. I asked her, “What is the threshold?” I’m a stage 4 lung cancer patient with brain metastasis. Forget the skin. I started to understand when things go very bad with the rash and why we may need to stop treatment.

Treatment can be flexible. Instead of every three weeks, you can do it every four weeks, like I do now. One week can make a lot of difference for patients. A patient needs to know that everything is flexible.

I’m very happy with my current doctor, who’s my third doctor. You need to advocate for yourself. With all due respect, doctors need to understand that they are working for us and not the other way around. The patient has the power. He can stop treatment. He can postpone treatment. It’s our life, so we have a say and we need to be heard. Otherwise, we can change the doctors or change the medical team. Everything can change.

Filipe P.

The Fear of Running Out of Treatment Options

Running out of options is scary. Research is very important. Without research, people would run out of treatments. Treatment can save lives. I’m an example of that. I believe that if it wasn’t for the drug I’m currently on, I wouldn’t be here, so it’s very important to have options.

Cancer is a monster, but there is hope.

My Biggest Advice for Lung Cancer Patients

There has been more development in lung cancer in the last five years than in the last 50, so there are a lot of things happening. Don’t look at the statistics. The data online is outdated. There is a lot of hope. Cancer is a monster, but there is hope.


Johnson & Johnson - J&J

Special thanks again to Johnson & Johnson for its support of our independent patient education content. The Patient Story retains full editorial control.


Filipe P. feature profile
Thank you for sharing your story, Filipe!

Inspired by Filipe's story?

Share your story, too!


More EGFR Lung Cancer Stories

Jennifer M. EGFR-positive lung cancer

Jennifer M., Non-Small Cell Lung Cancer, EGFR+, Stage 4 (Metastatic)



Symptoms: None per se; discovered during physical checkup for what seemed to be a sinus infection

Treatments: Radiation therapy (stereotactic body radiation therapy or SBRT), targeted therapy
Samantha V. stage 2 lung cancer

Samantha V., Lung Cancer, EGFR+, Stage 2, Grade 3



Symptoms: Breathlessness, hoarseness, sinus infections, fatigue, pain in left side

Treatments: Clinical trial (targeted therapy)

Natasha L. stage 4 lung cancer

Natasha L., Lung Cancer, EGFR+, Stage 4



Symptoms: Hoarse voice, squeaky breathing, cough, weight loss, fatigue

Treatment: Targeted therapy


Jeff S., Non-Small Cell Lung Cancer with EGFR exon 19 Deletion, Stage 4 (Metastatic)



Symptom: Slight cough

Treatments: Surgery, radiation, chemotherapy, targeted therapy

Jill F., Non-Small Cell Lung Cancer with EGFR Exon 19 Deletion, Stage 1A



Symptom: Nodule found during periodic scan

Treatments: Surgery, targeted therapy, radiation

Categories
Chemotherapy HER2 Immunotherapy Lung Cancer Non-Small Cell Lung Cancer Patient Stories Treatments

Samantha’s Stage 4 HER2 Non-Small Cell Lung Cancer Story

Samantha’s Stage 4 HER2-Lung Cancer Story

Interviewed by: Stephanie Chuang
Edited by: Katrina Villareal

Samantha M. feature profile

At 37, Samantha was diagnosed with HER2 non-small cell lung cancer. Her symptoms started with a cough and chest pressure, so she went to urgent care. A cancer diagnosis was one thing, but a lung cancer diagnosis with no smoking history was mind-numbing to her. This is Samantha’s story of navigating a lung cancer diagnosis young and discovering a rare biomarker too.


  • Name: Samantha M.
  • Age at Diagnosis:
    • 37
  • Diagnosis:
    • Non-Small Cell Lung Cancer (NSCLC)
  • Staging:
    • Stage 4
  • Mutation:
    • HER2
  • Symptoms:
    • Persistent cough
    • Chest pressure
    • Fatigue
    • Weight loss
  • Treatments:
    • Chemotherapy
    • Immunotherapy
Samantha M.

Bayer

Thank you to Bayer for its support of our patient education program! The Patient Story retains full editorial control over all content.

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider for treatment decisions.



I went on a women’s trip in March 2024. When I came back from the trip, I developed a cough and noticed some pressure on my chest.

Introduction

I was born in California, raised in Hong Kong and the UK, and went back to the US around 12 years ago. I’m an active, outdoor adventurer. I love hiking, backpacking, camping, and anything to do with nature and being outside.

My husband Justin and I have been married for seven years. He is my absolute world and soulmate. I also have a nine-year-old German Shepherd.

Samantha M.
Samantha M.

Pre-diagnosis

Initial Symptoms

I went on a women’s trip in March 2024. There were 20 of us going on this adventure together even though I had never met them before. We were going to travel to India for 10 days. Before the trip, everything felt completely normal.

When I came back from the trip, I developed a cough and noticed some pressure on my chest. The air is not the best in India. A lot of people developed a cough, so I didn’t think anything of it, but the chest pressure was bothering me.

Two weeks after my trip, I was still hiking 4 to 5 miles a day, but there was a lot of pressure going on. I went to urgent care where a doctor listened to my chest and said, “Let’s do a chest X-ray to see what’s going on.”

The results showed that my entire left lung was full of fluid and fully collapsed. He said, “You need to go to the emergency room immediately.” I was still very naive then, thinking it was something I contracted from my trip.

They said, ‘We had a chance to look at a biopsy of one of the lesions in your liver and the fluid in your lungs, and it’s looking to be more and more like cancer.’

Diagnosis

Getting a Cancer Diagnosis

I went to the emergency room and they admitted me right away. They put in a chest tube, which was not a pleasant experience, and ended up draining 3 liters of fluid from my lung. They took that off for testing and did multiple CT scans. Even though I was admitted to the hospital, I was getting information about my scans through the apps. My result came through before the doctor even spoke to me. It said multiple lesions on the liver and lungs.

The infectious disease doctor came in and started asking me a ton of questions. They thought I might have tuberculosis because I’d lived and traveled to a lot of foreign countries, so they were very confused and running tons of tests.

Unfortunately, on day three of the hospital admission, they said, “We had a chance to look at a biopsy of one of the lesions in your liver and the fluid in your lungs, and it’s looking to be more and more like cancer.” They couldn’t give me a guarantee at that point, but this was looking like it. They said, “We’re going to discharge you. We’ll wait for confirmation, but we’re lining up an oncology appointment for you right away.” That’s when my world spiraled.

Samantha M.
Samantha M.
Playing the Waiting Game

We were living in Missoula, Montana, where my husband was stationed. The wait for the general oncologist was two weeks. There was no specialist there. After all, it was such a small town. That period was awful. It was confirmed through the app that I did have cancer, but I had no doctor to bounce anything off or ask questions.

At that point, it didn’t say what stage I was, and not being too familiar, I didn’t know what stage 1 versus stage 4 meant. I had no idea. I didn’t know anything other than I had non-small cell lung cancer.

I was spiraling on Google, which is not your best friend at this time of diagnosis. I figured out I was stage 4 and learned the five-year survival rate. I was doing more digging and came across mutations all this information on mutations.

I was eventually diagnosed with HER2 mutation, which was one I had never heard of.

When I went into that initial oncology visit, I had a list of questions, but the number one was if I could get a biomarker test for genetic mutations. He said, “Absolutely. It was on my list. You’re good because I know a lot of oncologists in these smaller towns are still not aware of these biomarker testing and treat lung cancer when someone could have a targetable mutation.”

I learned a lot about mutations during that two-week waiting period. I was eventually diagnosed with HER2 mutation, which was one I had never heard of. I didn’t come across it on any websites. It was a two-week window of the unknown with the fear and concern that I didn’t have long to live.

At my first oncology appointment in Missoula, he told me that I was stage 4, I was terminal, and had nine months to live. He told me before he even knew what mutation I had. No one should be told how long they have to live like that. It doesn’t help anyone. It set my mind back a long way. It was devastating.

Samantha M.
Samantha M.
Reaction to the Diagnosis

My husband, who was a 19-year veteran at this point, used to be a combat medic in Iraq and Afghanistan, so he’s seen a lot and I had never seen him cry ever. When I got that diagnosis in Missoula, he went outside the hospital and broke down. That was hard to see and almost harder for me than receiving the news personally. We’re so young. It was heartbreaking because he’s my soulmate. Knowing that I’m not going to be around and be with him when we’re 80 years old is gut-wrenching.

It hit him hard. He’s been an incredible caregiver. He’s been to every single appointment. He now handles the app for me and looks at all of my results. He’s been exceptionally supportive. I couldn’t ask for a better caregiver, but I would say it’s probably had more of an impact on him than on me.

Honestly, I had a breakdown… I thought that was the end of my journey because there was no primary targeted treatment for HER2.

Seeing a Lung Cancer Specialist

My husband said, “We’ll see this oncologist here, but let’s get you to a research hospital. Let’s see if the army will move us.” Within a month, the army approved the move. We were 45 minutes away from the Huntsman Cancer Institute. They have been so supportive and my work has also been so supportive.

I’m very grateful because I know a lot of people are not in that situation, especially those who are young, have cancer, and work full-time jobs. We put our house up for sale and within a month of my diagnosis, we had fully moved to be settled and to see a lung oncologist in Salt Lake City.

I learned to advocate for myself constantly. I was pretty forceful in messaging the Huntsman saying, “I need to get in as soon as possible. The general oncologist referred me. This is their letter.”

Samantha M.
Samantha M.

I was fortunate to get the best thoracic oncologist at the Huntsman. They looked at my chart and saw the severity of my stage 4 diagnosis. They got me in very quickly and wanted to redo my scans. They did a CT scan and a PET scan, which I hadn’t had at that point. They said, “We’re sending biomarker testing off the blood and also take a sample from Missoula and submit that as a tissue sample.”

They didn’t want to start any treatment until my biomarker test results came back, which took about two weeks. Meanwhile, my lung was continuing to fill up with fluid, so I had to get drained regularly. I was still active and nothing was stopping me. I was hiking at 10,000-foot elevation and I had no issues, but I felt very, very tired.

My biomarker test results came back and said HER2. I had never heard of HER2 in my life. I thought, “What on earth is this? What am I going to do with this?”

Honestly, I had a breakdown because I had been part of groups that talked about EGFR and ALK, all these great drugs, and people doing so well as young people on these targeted therapies. I said, “This is it. I keep on getting hit over and over again with bad luck and this is the final straw.” I thought that was the end of my journey because there was no primary targeted treatment for HER2.

Learning About the HER2 Biomarker

I started researching on Google, which wasn’t the best idea because when you search lung cancer and HER2, it says you do not have a very good prognosis at all and that wasn’t what I wanted to hear. That and not seeing anything about a primary targeted therapy was heartbreaking.

Samantha M.
Samantha M.
Finding Hope While Learning from Other Patients’ Experiences

I was introduced to someone who is part of an exon 20 group. I spoke to her within 24 hours of knowing that I had HER2 and she spent about an hour explaining everything: what was on the horizon as far as treatment was concerned, what was currently under clinical trials, and all of this hope.

I went from absolute turmoil, thinking this was literally the end, and that I have the worst prognosis to there could actually be some hope here and that changed my entire attitude. A lot of HER2 patients, when they find out about their mutation, aren’t told about the hope. They aren’t told about what’s coming. People have no idea unless they’re educated by other people.

I wanted to start treatment, so we decided on traditional chemo and immunotherapy and started that within a week.

Treatment

Treatment Options for HER2 Mutation

My oncologist is incredible. He called me right away and said, “Look. This isn’t what I was expecting either, but this is what we have.” He was trying to find silver linings. He said, “You have to come in every three weeks to get treatment, but your mutation works with immunotherapy. Your mutation can work with traditional chemo.” He was giving me some hope and that’s all I needed to hear.

He wasn’t an expert in HER2. I don’t think he has any other HER2 patients, but I was also fortunate because my coworker’s husband’s best friend is a HER2 expert and he’s been an incredible resource who I can text and get information or reassurance. Having those two resources has been invaluable.

My oncologist laid out what chemotherapy and immunotherapy I would be on. He also offered up a clinical trial, which split chemo and immunotherapy separately by a week, instead of combining them for a couple of rounds. He thought that I would be a good candidate.

Samantha M.
Samantha M.

Meanwhile, the HER2 expert who I was talking to was telling me about an amazing clinical trial for a drug for HER2 that was looking for people who had not been treated yet. My oncologist didn’t know about that trial, so I brought it up with him and he was kind enough to look into the research, look into the statistics, and weigh the options for me.

He said, “At the end of the day, it’s up to you which one you would like to proceed with, but here are my thoughts.” He was leaning towards traditional chemo and immunotherapy because immunotherapy had foundational success in the long run. The clinical trial was still in its early days in knowing what the outcome would be in the long term.

I also didn’t want to wait. Joining a clinical trial in another hospital involved flying, getting scans again, etc. I wanted to start treatment, so we decided on traditional chemo and immunotherapy and started that within a week.

As weird as it is to say this as a stage 4 cancer patient, chemotherapy and immunotherapy can do wonders.

Response to Treatment

I was responding extremely well and I’m very fortunate that I don’t have that many side effects at all. I have a couple of days of low energy, but other than that, I have been able to live my life, hike, and work.

I spoke to my husband and as weird as it is to say this as a stage 4 cancer patient, chemotherapy and immunotherapy can do wonders. There’s a horrible misconception that chemo and immunotherapy are awful and they don’t do anything. I get very upset about that because it has changed my life and has done amazing things for my body. I haven’t felt this well in years.

Looking back, even though I didn’t have very apparent symptoms, I was tired all the time. I would take naps during the day. I would be exhausted after 10 hours of sleep. I lost five pounds when I’ve never lost weight in my life. There were very subtle signs and if you look at pictures of me, I didn’t look well.

I’m feeling great right now. It’s like a double-edged sword because I have stage 4 cancer, but the chemo and immunotherapy are reducing my cancer burden so much that I feel like normal Samantha again.

Samantha M.
Samantha M.

Having Hope with a HER2 Biomarker

There’s a lot of hope. A HER2 mutation is not an immediate death sentence by any means. We don’t have a targeted therapy right now but that doesn’t mean it’s the end of the line. There are options out there.

Knowing that there are targeted therapies coming out very soon through clinical trials with statistics that show that they work exceptionally well is invaluable.

There’s a lot of hope. A HER2 mutation is not an immediate death sentence by any means.

Words of Advice

You see online that if you eat healthy and you exercise, there’s a very low chance you’re going to get cancer and I don’t like that at all. It makes me very angry and very upset because that makes people who are fit and healthy and doing all the right things think that they’re not going to be touched by cancer.

People must be aware that cancer does not discriminate. It doesn’t care if you’re fit and healthy. It will be in whoever it wants to be and that’s a fact.

Listen to your body. Be in touch with changes. If you have a lump, if you have a weird cough that has continued for months, if you have a weird mole that you’re not sure about, don’t wait.

If your gut is telling you something is wrong and your doctor says it’s fine and not to worry about it, get a second opinion. Push and be that person and get the answers you need to get. You have to advocate for yourself.

Samantha M.

Bayer

Special thanks again to Bayer for its support of our independent patient education content. The Patient Story retains full editorial control.


Samantha M. feature profile
Thank you for sharing your story, Samantha!

Inspired by Samantha's story?

Share your story, too!


More Non-Small Cell Lung Cancer Stories

Jennifer M. EGFR-positive lung cancer

Jennifer M., Non-Small Cell Lung Cancer, EGFR+, Stage 4 (Metastatic)



Symptoms: None per se; discovered during physical checkup for what seemed to be a sinus infection

Treatments: Radiation therapy (stereotactic body radiation therapy or SBRT), targeted therapy
Dr. Ross Camidge stage 4 lung cancer

Dr. Ross Camidge, Non-Small Cell Lung Cancer, Stage 4 (Metastatic)



Symptoms: sore shoulder muscle, breathing sounded different
Laura R. ALK+ lung cancer

Laura R., Non-Small Cell Lung Cancer, ALK+, Stage 4 (Metastatic)



Symptoms: Persistent cough, fatigue, bone pain

Treatments: Targeted therapies (tyrosine kinase inhibitors or TKIs, including through a clinical trial)
Drea C. stage 4 ROS1+ lung cancer

Drea C., Non-Small Cell Lung Cancer, ROS1+, Stage 4 (Metastatic)



Symptoms: Swollen ankle resulting from a deep vein thrombosis or blood clot, mysterious bruising, extreme weight loss, persistent shortness of breath, rattling sound coming from the throat while breathing

Treatments: Radiation therapy, chemotherapy, targeted therapies
Lysa B. stage 4 ROS1+ lung cancer

Lysa B., Non-Small Cell Lung Cancer, ROS1+, Stage 4 (Metastatic)



Symptom: Severe but intermittent back pain

Treatments: Chemotherapy, radiation therapy, targeted therapy (including through a clinical trial), surgeries (lung resection, metastatic spine tumor surgery)